Viatris rises after Japan approves anxiety disorder drug

Shares of drugmaker Viatris VTRS.O rise 2% to $13.47 premarket

Co says Japan approved its drug Effexor to treat generalized anxiety disorder

Approval makes Effexor the first medicine cleared for the condition in Japan, co says

Effexor, also known as venlafaxine, was already approved in Japan for depression - company

Decision follows a late‑stage study in Japan that showed the drug eased anxiety symptoms better than placebo after eight weeks, with limited dropouts due to side effects - co

Drug is already approved for anxiety disorder in more than 80 countries outside Japan - VTRS

As of last close, stock up ~6% YTD